Literature DB >> 2581315

Expression of the chlamydial genus-specific lipopolysaccharide epitope in Escherichia coli.

F E Nano, H D Caldwell.   

Abstract

The obligate intracellular prokaryote Chlamydia trachomatis is the etiological agent of trachoma and is a primary causative pathogen of sexually transmitted genital tract disease; both diseases affect millions of people each year. The cloning of genes encoding the enzyme or enzymes producing the genus-specific lipopolysaccharide antigen of Chlamydia into Escherichia coli is reported here. The cloned chlamydial lipopolysaccharide antigen appears to be a hybrid lipopolysaccharide molecule composed of both Chlamydia and Escherichia coli components. The chlamydial lipopolysaccharide antigen is expressed on the surfaces of the viable Escherichia coli recombinants. These findings may have a significant impact on defining the role of this highly conserved antigen in the pathogenesis and diagnosis of chlamydial infections.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2581315     DOI: 10.1126/science.2581315

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  29 in total

1.  Staining of surface antigens of Chlamydia trachomatis L2 in tissue culture.

Authors:  M Baumann; L Brade; E Fasske; H Brade
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

2.  Comparison of Chlamydia psittaci isolates by restriction endonuclease and DNA probe analyses.

Authors:  P Timms; F W Eaves; A A Girjes; M F Lavin
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

3.  Construction of physical and genetic maps of Chlamydia trachomatis serovar L2 by pulsed-field gel electrophoresis.

Authors:  S Birkelund; R S Stephens
Journal:  J Bacteriol       Date:  1992-05       Impact factor: 3.490

4.  Chemical cross-linking of Chlamydia trachomatis.

Authors:  S Birkelund; A G Lundemose; G Christiansen
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

5.  Chlamydial hemagglutinin identified as lipopolysaccharide.

Authors:  N G Watkins; H D Caldwell; T Hackstadt
Journal:  J Bacteriol       Date:  1987-08       Impact factor: 3.490

Review 6.  Lipopolysaccharide nomenclature--past, present, and future.

Authors:  P J Hitchcock; L Leive; P H Mäkelä; E T Rietschel; W Strittmatter; D C Morrison
Journal:  J Bacteriol       Date:  1986-06       Impact factor: 3.490

7.  Interchangeable domains in the Kdo transferases of Escherichia coli and Haemophilus influenzae.

Authors:  Hak Suk Chung; Christian R H Raetz
Journal:  Biochemistry       Date:  2010-05-18       Impact factor: 3.162

8.  Lipopolysaccharide smooth-rough phase variation in bacteria of the genus Chlamydia.

Authors:  M Lukácová; M Baumann; L Brade; U Mamat; H Brade
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

9.  Recombinant Escherichia coli clones expressing Chlamydia trachomatis gene products attach to human endometrial epithelial cells.

Authors:  D H Schmiel; S T Knight; J E Raulston; J Choong; C H Davis; P B Wyrick
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

10.  Characterization of murine monoclonal and murine, rabbit, and human polyclonal antibodies against chlamydial lipopolysaccharide.

Authors:  L Brade; O Holst; P Kosma; Y X Zhang; H Paulsen; R Krausse; H Brade
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.